共 50 条
- [21] Phase II Trial of Brostallicin and Cisplatin in Patients with Metastatic Triple Negative Breast Cancer.CANCER RESEARCH, 2011, 71Moreno-Aspitia, A.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Jacksonville, FL 32224 USA Mayo Clin, Jacksonville, FL 32224 USARowland, K. M.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Jacksonville, FL 32224 USA Mayo Clin, Jacksonville, FL 32224 USALiu, H.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Jacksonville, FL 32224 USA Mayo Clin, Jacksonville, FL 32224 USAHillman, D. W.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Jacksonville, FL 32224 USA Mayo Clin, Jacksonville, FL 32224 USAStella, P. J.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Jacksonville, FL 32224 USA Mayo Clin, Jacksonville, FL 32224 USAPerez, E. A.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Jacksonville, FL 32224 USA Mayo Clin, Jacksonville, FL 32224 USA
- [22] A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-Negative Breast CancersCLINICAL BREAST CANCER, 2016, 16 (03) : E57 - E59Roviello, Giandomenico论文数: 0 引用数: 0 h-index: 0机构: Univ Brescia, Sect Pharmacol, Brescia, Italy Univ Brescia, Dept Mol & Translat Med, Univ Ctr DIFF Drug Innovat Forward Future, Brescia, Italy Univ Brescia, Sect Pharmacol, Brescia, ItalyMilani, Manuela论文数: 0 引用数: 0 h-index: 0机构: AO Azienda Ist Ospitalieri Cremona, US Terapia Mol & Farmacogen, Cremona, Italy Univ Brescia, Sect Pharmacol, Brescia, ItalyGobbi, Angela论文数: 0 引用数: 0 h-index: 0机构: AO Azienda Ist Ospitalieri Cremona, US Terapia Mol & Farmacogen, Cremona, Italy Univ Brescia, Sect Pharmacol, Brescia, ItalyCappelletti, Maria Rosa论文数: 0 引用数: 0 h-index: 0机构: AO Azienda Ist Ospitalieri Cremona, US Terapia Mol & Farmacogen, Cremona, Italy Univ Brescia, Sect Pharmacol, Brescia, ItalyZanotti, Laura论文数: 0 引用数: 0 h-index: 0机构: AO Azienda Ist Ospitalieri Cremona, US Terapia Mol & Farmacogen, Cremona, Italy Univ Brescia, Sect Pharmacol, Brescia, ItalySenti, Chiara论文数: 0 引用数: 0 h-index: 0机构: AO Azienda Ist Ospitalieri Cremona, US Terapia Mol & Farmacogen, Cremona, Italy Univ Brescia, Sect Pharmacol, Brescia, ItalyBottini, Alberto论文数: 0 引用数: 0 h-index: 0机构: AO Azienda Ist Ospitalieri Cremona, US Terapia Mol & Farmacogen, Cremona, Italy Univ Brescia, Sect Pharmacol, Brescia, ItalyStrina, Carla论文数: 0 引用数: 0 h-index: 0机构: AO Azienda Ist Ospitalieri Cremona, US Terapia Mol & Farmacogen, Cremona, Italy Univ Brescia, Sect Pharmacol, Brescia, Italy论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:
- [23] A phase Ib/II study of eribulin (ERI) plus pembrolizumab (PEMBRO) in metastatic triple-negative breast cancer (mTNBC) (ENHANCE 1).JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)Tolaney, Sara M.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAKalinsky, Kevin论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAKaklamani, Virginia G.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAD'Adamo, David R.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAAktan, Gursel论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USATsai, Michaela L.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAO'Regan, Ruth论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAKaufman, Peter A.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAWilks, Sharon论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAAndreopoulou, Eleni论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAPatt, Debra A.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAYuan, Yuan论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAWang, Grace论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAXing, Dongyuan论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAKleynerman, Ella论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAKarantza, Vassiliki论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USADiab, Sami论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA
- [24] A phase I/II trial of olaparib tablet in combination with eribulin in Japanese patients with advanced or metastatic triple-negative breast cancer previously treated with anthracyclines and taxanesEUROPEAN JOURNAL OF CANCER, 2019, 109 : 84 - 91Yonemori, Kan论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Expt Therapeut, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, JapanShimomura, Akihiko论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Expt Therapeut, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, JapanYasojima, Hiroyuki论文数: 0 引用数: 0 h-index: 0机构: Osaka Natl Hosp, Breast Oncol, Dept Surg, Natl Hosp Org,Chuo Ku, 2-1-14 Houensaka, Osaka 5400006, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, JapanMasuda, Norikazu论文数: 0 引用数: 0 h-index: 0机构: Osaka Natl Hosp, Breast Oncol, Dept Surg, Natl Hosp Org,Chuo Ku, 2-1-14 Houensaka, Osaka 5400006, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, JapanAogi, Kenjiro论文数: 0 引用数: 0 h-index: 0机构: Shikoku Canc Ctr, Dept Breast Surg, Natl Hosp Org, 160 Kou,Minamiumemoto Cho, Matsuyama, Ehime 7910280, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, JapanTakahashi, Masato论文数: 0 引用数: 0 h-index: 0机构: Hokkaido Canc Ctr, Dept Breast Surg, Natl Hosp Org, Shiraishi Ku, 3-54 Kikusui Sijou, Sappro, Hokkaido 0030804, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, JapanNaito, Yoichi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Breast & Med Oncol, Natl Canc Ctr, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, JapanShimizu, Satoru论文数: 0 引用数: 0 h-index: 0机构: Kanagawa Canc Ctr, Dept Breast Surg, Asahi Ku, 2-3-2 Nakao, Yokohama, Kanagawa 2418515, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, JapanNakamura, Rikiya论文数: 0 引用数: 0 h-index: 0机构: Chiba Canc Ctr, Dept Breast Surg, Chuo Ku, 666-2 Nitona Cho, Chiba 2608717, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, JapanHashimoto, Jun论文数: 0 引用数: 0 h-index: 0机构: St Lukes Int Hosp, Div Med Oncol, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, JapanYamamoto, Harukaze论文数: 0 引用数: 0 h-index: 0机构: Kumamoto Med Ctr, Dept Med Oncol, Natl Hosp Org, Chuo Ku, 1-5 Ninomaru, Kumamoto 8600008, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, JapanHirakawa, Akihiro论文数: 0 引用数: 0 h-index: 0机构: Univ Tokyo, Grad Sch Med, Dept Biostat & Bioinformat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138654, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan论文数: 引用数: h-index:机构:Hamada, Akinobu论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Res Inst, Div Mol Pharmacol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, JapanYoshida, Teruhiko论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Natl Canc Ctr, Dept Genet Med & Serv, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, JapanSukigara, Tamie论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Natl Canc Ctr, Clin Res Support Off, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, JapanTamura, Kenji论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, JapanFujiwara, Yasuhiro论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan Natl Canc Ctr, Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan
- [25] A phase II trial of olaparib and durvalumab in metastatic BRCA wild type triple-negative breast cancer.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Mitri, Zahi Ibrahim论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USAVuky, Jacqueline论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USAKemmer, Kathleen A.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USASavin, Michael A.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USAParmar, Swapnil论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USAKolodzie, Annette Kolodzie论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USAJohnson, Brett论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USAWilliams-Belizaire, Rochelle论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USAGray, Joe W.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USAMills, Gordon B.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USA
- [26] A phase Ib study of TQB2450 plus anlotinib in patients with advanced triple-negative breast cancer.JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Wang, Jiayu论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R ChinaXu, Binghe论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R ChinaSun, Tao论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R ChinaOuyang, Quchang论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R ChinaHan, Yiqun论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R ChinaLi, Qing论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R ChinaZhang, Pin论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R ChinaMa, Fei论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R ChinaLuo, Yang论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R ChinaFan, Ying论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R ChinaCai, Ruigang论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R ChinaLi, Qiao论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R ChinaLan, Bo论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R ChinaMo, Hongnan论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R ChinaWang, Jiani论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R ChinaLi, Yiqun论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R China
- [27] A phase Ib study of camrelizumab in combination with apatinib and fuzuloparib in patients with recurrent or metastatic triple-negative breast cancerBMC MEDICINE, 2022, 20 (01)Zhang, Qingyuan论文数: 0 引用数: 0 h-index: 0机构: Harbin Med Univ Canc Hosp, Dept Breast Oncol, Harbin, Peoples R China Harbin Med Univ Canc Hosp, Dept Breast Oncol, Harbin, Peoples R ChinaShao, Bin论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Dept Breast Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, 52 Fucheng Rd, Beijing 100142, Peoples R China Harbin Med Univ Canc Hosp, Dept Breast Oncol, Harbin, Peoples R ChinaTong, Zhongsheng论文数: 0 引用数: 0 h-index: 0机构: Tianjin Med Univ Canc Inst & Hosp, Dept Breast Oncol, Tianjin, Peoples R China Harbin Med Univ Canc Hosp, Dept Breast Oncol, Harbin, Peoples R ChinaOuyang, Quchang论文数: 0 引用数: 0 h-index: 0机构: Hunan Canc Hosp, Dept Breast Oncol, Changsha, Peoples R China Harbin Med Univ Canc Hosp, Dept Breast Oncol, Harbin, Peoples R ChinaWang, Yuting论文数: 0 引用数: 0 h-index: 0机构: Jiangsu Hengrui Pharmaceut Co Ltd, Clin Res & Dev, Shanghai, Peoples R China Harbin Med Univ Canc Hosp, Dept Breast Oncol, Harbin, Peoples R ChinaXu, Guoying论文数: 0 引用数: 0 h-index: 0机构: Jiangsu Hengrui Pharmaceut Co Ltd, Clin Res & Dev, Shanghai, Peoples R China Harbin Med Univ Canc Hosp, Dept Breast Oncol, Harbin, Peoples R ChinaLi, Shaorong论文数: 0 引用数: 0 h-index: 0机构: Jiangsu Hengrui Pharmaceut Co Ltd, Clin Res & Dev, Shanghai, Peoples R China Harbin Med Univ Canc Hosp, Dept Breast Oncol, Harbin, Peoples R ChinaLi, Huiping论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Dept Breast Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, 52 Fucheng Rd, Beijing 100142, Peoples R China Harbin Med Univ Canc Hosp, Dept Breast Oncol, Harbin, Peoples R China
- [28] A phase Ib study of camrelizumab in combination with apatinib and fuzuloparib in patients with recurrent or metastatic triple-negative breast cancerBMC Medicine, 20Qingyuan Zhang论文数: 0 引用数: 0 h-index: 0机构: Harbin Medical University Cancer Hospital,Department of Breast OncologyBin Shao论文数: 0 引用数: 0 h-index: 0机构: Harbin Medical University Cancer Hospital,Department of Breast OncologyZhongsheng Tong论文数: 0 引用数: 0 h-index: 0机构: Harbin Medical University Cancer Hospital,Department of Breast OncologyQuchang Ouyang论文数: 0 引用数: 0 h-index: 0机构: Harbin Medical University Cancer Hospital,Department of Breast OncologyYuting Wang论文数: 0 引用数: 0 h-index: 0机构: Harbin Medical University Cancer Hospital,Department of Breast OncologyGuoying Xu论文数: 0 引用数: 0 h-index: 0机构: Harbin Medical University Cancer Hospital,Department of Breast OncologyShaorong Li论文数: 0 引用数: 0 h-index: 0机构: Harbin Medical University Cancer Hospital,Department of Breast OncologyHuiping Li论文数: 0 引用数: 0 h-index: 0机构: Harbin Medical University Cancer Hospital,Department of Breast Oncology
- [29] Patterns of mutation enrichment in metastatic triple-negative breast cancer.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Saravia, Cesar H.论文数: 0 引用数: 0 h-index: 0机构: Univ Privada San Juan Bautista, Escuela Med Humana, Lima, PeruFlores, Claudio J.论文数: 0 引用数: 0 h-index: 0机构: Univ Privada San Juan Bautista, Escuela Med Humana, Lima, PeruSchwarz, Luis Jesus论文数: 0 引用数: 0 h-index: 0机构: Univ Privada San Juan Bautista, Escuela Med Humana, Lima, PeruBravo, Leny论文数: 0 引用数: 0 h-index: 0机构: Univ Privada San Juan Bautista, Escuela Med Humana, Lima, PeruZavaleta, Jenny论文数: 0 引用数: 0 h-index: 0机构: Univ Privada San Juan Bautista, Escuela Med Humana, Lima, PeruAraujo, Jhajaira M.论文数: 0 引用数: 0 h-index: 0机构: Univ Privada San Juan Bautista, Escuela Med Humana, Lima, PeruNeciosup, Silvia P.论文数: 0 引用数: 0 h-index: 0机构: Univ Privada San Juan Bautista, Escuela Med Humana, Lima, PeruPinto, Joseph A.论文数: 0 引用数: 0 h-index: 0机构: Univ Privada San Juan Bautista, Escuela Med Humana, Lima, Peru
- [30] Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer.NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (03): : 205 - 214O'Shaughnessy, Joyce论文数: 0 引用数: 0 h-index: 0机构: Baylor Charles A Sammons Canc Ctr, Dallas, TX USA US Oncol, Dallas, TX USA Texas Oncol, Dallas, TX USA Baylor Charles A Sammons Canc Ctr, Dallas, TX USAOsborne, Cynthia论文数: 0 引用数: 0 h-index: 0机构: Baylor Charles A Sammons Canc Ctr, Dallas, TX USA US Oncol, Dallas, TX USA Texas Oncol, Dallas, TX USA Baylor Charles A Sammons Canc Ctr, Dallas, TX USAPippen, John E.论文数: 0 引用数: 0 h-index: 0机构: Baylor Charles A Sammons Canc Ctr, Dallas, TX USA US Oncol, Dallas, TX USA Texas Oncol, Dallas, TX USA Baylor Charles A Sammons Canc Ctr, Dallas, TX USAYoffe, Mark论文数: 0 引用数: 0 h-index: 0机构: US Oncol, Dallas, TX USA Canc Ctr N Carolina, Raleigh, NC USA Baylor Charles A Sammons Canc Ctr, Dallas, TX USAPatt, Debra论文数: 0 引用数: 0 h-index: 0机构: US Oncol, Dallas, TX USA Texas Oncol Canc Ctr, Austin, TX USA Baylor Charles A Sammons Canc Ctr, Dallas, TX USARocha, Christine论文数: 0 引用数: 0 h-index: 0机构: BiPar Sci, San Francisco, CA USA Baylor Charles A Sammons Canc Ctr, Dallas, TX USAKoo, Ingrid Chou论文数: 0 引用数: 0 h-index: 0机构: BiPar Sci, San Francisco, CA USA Baylor Charles A Sammons Canc Ctr, Dallas, TX USASherman, Barry M.论文数: 0 引用数: 0 h-index: 0机构: BiPar Sci, San Francisco, CA USA Baylor Charles A Sammons Canc Ctr, Dallas, TX USABradley, Charles论文数: 0 引用数: 0 h-index: 0机构: BiPar Sci, San Francisco, CA USA Baylor Charles A Sammons Canc Ctr, Dallas, TX USA